GOLD and ABCD--a good start, but now for the evidence?

Affiliations

Comment

Jadwiga A Wedzicha. Lancet Respir Med. 2013 Mar.

. 2013 Mar;1(1):4-5.

doi: 10.1016/S2213-2600(12)70045-0. Epub 2012 Sep 3.

¹ Centre for Respiratory Medicine, Royal Free Campus, University College London, London NW3 2PF, UK. Electronic address: w.wedzicha@ucl.ac.uk.

No abstract available

Comment in

GOLD COPD categories are not fit for purpose in primary care.
Jones R, Price D, Chavannes N, van de Molen T, Thomas M, Tsiligianni I, Williams S. Jones R, et al. Lancet Respir Med. 2013 Mar;1(1):e17. doi: 10.1016/S2213-2600(13)70015-8. Epub 2013 Mar 4. Lancet Respir Med. 2013. PMID: 24321812 No abstract available.
GOLD COPD categories are not fit for purpose in primary care--authors' reply.
Han MK, Lange P, Anzueto A, Martinez FJ, Jones PW. Han MK, et al. Lancet Respir Med. 2013 Mar;1(1):e17-8. doi: 10.1016/S2213-2600(13)70016-X. Epub 2013 Mar 4. Lancet Respir Med. 2013. PMID: 24321813 No abstract available.

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, Bowler RP, Beaty TH, Hokanson JE, Lynch DA, Jones PW, Anzueto A, Martinez FJ, Crapo JD, Silverman EK, Make BJ. Han MK, et al. Lancet Respir Med. 2013 Mar;1(1):43-50. doi: 10.1016/S2213-2600(12)70044-9. Epub 2012 Sep 3. Lancet Respir Med. 2013. PMID: 24321803 Free PMC article. Clinical Trial.